Variation in 5′ promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: The Copenhagen city heart study

Annals of Human Genetics

Volumn 71, Issue 6, 2007, Pages 762-771

  Stengard J H ^a   Frikke Schmidt, R ^b   Tybjaerg Hansen A ^b   Nordestgaard, B G ^c   Sing, C F ^d  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Rigshospitalet   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

APOE gene; Prediction of IHD; Regulatory variation

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DENMARK; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; BIOLOGICAL MODEL; BLOOD; GENETICS; HEART MUSCLE ISCHEMIA; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS E; CHOLESTEROL, HDL; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 34948875758     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2007.00370.x     Document Type: Article

References (51)

1. Artiga, M. J., Bullido, M. J., Sastre, I. et al. (1998) Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 421, 105-108.
2. Barrett-Connor, E. & Khaw, K-T. (1984) Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 69, 1065-1069.
3. Crawford, D. C., Carlson, C. S., Rieder, M. J. et al. (2004) Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations. Am J Hum Genet 74, 610-622.
4. Davignon, J., Cohn, J. S., Mabile, L. et al. (1999) Apolipoprotein E and atherosclerosis: Insight from animal and human studies. Clin Chim Acta 286, 115-143.
5. Davignon, J., Gregg, R. E. & Sing, C. F. (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
6. De Backer, G., Ambrosioni, E., Borch-Johnsen, K. et al. (2003) European guidelines on cardiovascular disease prevention in clinical practice: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 24, 1601-1610.
7. Everitt, B. S. (1994) Statistical methods for medical investigations. New York, NY: Halsted Press.
8. Fletcher, R. W. & Fletcher, S. W. (2005) Clinical epidemiology; the essentials. Philadelphia, PA: Lippincott Williams & Wilkins.
9. Freimer, N. & Sabatti, C. (2004) The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology. Nat Genet 36, 1045-1051.
10. Frikke-Schmidt, R., Nordestgaard, B. G., Agerholm-Larsen, B. et al. (2000a) Context-dependent and invariant associations between lipids, lipoproteins, and apolipoproteins and apolipoprotein E genotype. J Lipid Res 41, 1812-1822.
11. Frikke-Schmidt, R., Sing, C. F., Nordestgaard, B. G. et al. (2007) Subsets of SNPs define rare genotype classes that predict ischemic heart disease. Hum Genet 120, 865-877.
12. Frikke-Schmidt, R., Sing, C. F., Nordestgaard, B. G. et al. (2004) Gender- and age-specific contributions of additional DNA sequence variation in the 5′ regulatory region of the APOE gene to prediction of measures of lipid metabolism. Hum Genet 115, 331-345.
13. Frikke-Schmidt, R., Tybjærg-Hansen, A., Steffensen, R. et al. (2000b) Apolipoprotein E genotype: Epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 35, 1192-1199.
14. Fullerton, S. M., Buchanan, A. V., Sonpar, V. et al. (2004) The effects of scale: Variation in the APOA1/C3/A4/A5 gene cluster. Hum Genet 115, 36-56.
15. Fullerton, S. M., Clark, A. G., Weiss, K. M. et al. (2000) Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67, 881-900.
16. Guttmacher, A. E. & Collins, F. S. (2005) Realizing the promise of genomics in biomedical research. JAMA 294, 1399-1402.
17. Hixson, J. E. & Vernier, D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31, 545-548.
18. Ioannidis, J. P., Ntzani, E. E., Trikalinos, T. A. et al. (2001) Replication validity of genetic association studies. Nat Genet 29, 306-309.
19. Knoblauch, H., Bauerfeind, A., Toliat, M. R. et al. (2004) Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol. Mol Genet 13, 993-1004.
20. Lambert, J. C., Brousseau, T., Defosse, V. et al. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet 9, 57-61.
21. Lambert, J. C., Coyle, N. & Lendon, C. (2004) The allelic modulation of apolipoprotein E expression by oestrogen: Potential relevance for Alzheimer's disease. J Med Genet 41, 104-112.
22. Lambert, J. C., Mann, D., Richard, F. et al. (2005) Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease? J Neurol Neurosurg Psychiatry 76, 928-933.
23. Lehtinen, S., Lehtimäki, T., Sisto, T. et al. (1995) Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 114, 83-91.
24. Lussier-Cacan, S., Bolduc, A., Xhignesse, M. et al. (2002) Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and Apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 22, 824-831.
25. Mahley, R. W. (1988) Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
26. Mahley, R. W. & Rall, S. C. Jr. (2000) Apolipoprotein E: Far more than a lipid transport protein. In: Annual review of genomics and human genetics, eds. E. Lander, D. Page, & E. Lifton, pp 507-538. Palo Alto, CA: Annual Reviews Inc.
27. Miettinen, T. A., Gylling, H., Vanhanen, H. et al. (1992) Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12, 1044-1052.
28. Nabel, E. G. (2003) Cardiovascular disease. N Engl J Med 349, 60-72.
29. National Cholesterol Education Program National Heart, Lung, and Blood Institute (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Washington, DC: NIH Publication No 02-5215, September.
30. Nelson, M. R., Kardia, S. L., Ferrell, R. et al. (2001) A CPM to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res 11, 458-470.
31. Nickerson, D. A. (2005) Department of Genome Sciences University of Washington; Nickerson Group, MDECODE; SNP data: http://droog.gs.washington.edu/mdecode
32. Nickerson, D. A., Taylor, S. L., Fullerton, S. M. et al. (2000) Sequence diversity and large scale typing of SNPs in the human apolipoprotein E gene. Genome Res 10, 1532-1545.
33. Ober, C., Aldrich, C. L., Chervoneva, I. et al. (2003) Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 72, 1425-1435.
34. Rea, T. J., Brown, C. M. & Sing, C. F. (2006) Complex adaptive system models and the gene analysis of plasma HDL-Cholesterol concentration. Perspect Biol Med 49, 490-503.
35. Russell, B. (1945) A history of western philosophy, New York, NY: Simon and Schuster.
36. Schnohr, P., Jensen, G., Lange, P. et al. (2001) The Copenhagen City Heart Study. Tables with data from the third examination 1991-1994. Eur Heart J 3 (Suppl H), 1-83.
37. Sing, C. F., Stengård, J. H. & Kardia, S. L. R. (2004) Dynamic relationships between the genome and exposures to environments as causes of common human diseases. In: Nutrigenetics and Nutrigenomics (World Review of Nutrition and Dietetics) eds A.P. Simopoulos & J.M. Ordovas, vol 93; pp 77-91. Switzerland: Karger.
38. Sokal, R. R. & Rohlf, F. J. (1995) Biometry: The principles and practice of statistics in biological research (3rd ed), New York, NY: WH Freeman and Company.
39. Song, Y., Stampfer, M. J. & Liu, S. (2004) Meta-analysis: apolipoprotein e genotypes and risk for coronary heart disease. Ann Intern Med 141, 137-147.
40. Sposito, A.C., Gonbert, S., Turpin, G. et al. (2004) Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels. Arterioscler Thromb Vasc Biol 24, 2192-2195.
41. Steinberg, D. (2004) An interpretive history of the cholesterol controversy: Part 1. J Lipid Res 45, 1583-1593.
42. Stengård, J. H., Clark, A. G., Weiss, K. M. et al. (2002) Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet S71, 501-517.
43. Stengård, J. H., Kardia, S. L. R., Hamon, S. C. et al. (2006) Contribution of regulatory and structural variations in APOE to predicting dyslipidemia. J Lipid Res 47, 318-328.
44. Stengård, J. H., Kardia, S. L. R., Tervahauta, M. et al. (1999) Utility of the predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men aged 65 to 84 years is dependent on context defined by Apo E genotype and area of residence. Clin Genet 56, 367-377.
45. Stengård, J. H., Zerba, K. E., Pekkanen, J. et al. (1995) Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 91, 265-269.
46. Talmud, P. J., Stephens, J. W., Hawe, E. et al. (2005) The significant increase in cardiovascular disease risk in APOE ε4 carriers is evident only in men who smoke: Potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet 69, 1-10.
47. Utermann, G., Hees, M. & Steinmetz, A. (1977) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man. Nature 269, 604-607.
48. van Asselt, K. M., Kok, H. S., van der Schouw, Y. T. et al. (2006) Role of genetic analyses in cardiology: Part II: Heritability estimation for gene searching in multifactorial diseases. Circulation 113, 1136-1139.
49. Viiri, L.E., Loimaala, A., Nenonen, A. et al. (2005) The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 179, 161-167.
50. Viitanen, L., Pihlajamäki, J., Miettinen, R. et al. (2001) Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease. J Mol Med 79, 732-737.
51. Ye, S., Dunleavey, L., Bannister, W. et al. (2003) Independent effects of the -219G > T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study. Eur J Hum Genet 11, 437-443.